Counsyl - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCounsyl
Counsyl logo

Counsyl

0 followers

About Counsyl

Myriad Genetics is a genetic testing company focused on hereditary cancer risk, prenatal screening, oncology, and mental health pharmacogenomics. The company provides germline and tumor genomic testing to guide cancer risk assessment, treatment decisions, and prevention strategies, with a global reach including the United States and international locations. Its offerings include a broad catalog of genetic tests and patient/provider resources designed to support diagnosis, prognosis, and personalized care across multiple health areas. Headquartered in the United States, Myriad emphasizes actionable genetic insights to improve patient outcomes and advance precision medicine.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Jerry Lanchbury

Chief Scientific Officer (CSO)

Paul J. Diaz

President and CEO

Mark Skolnick

Founder

Kevin Kimberlin

Founder

Peter Meldrum

Founder

Key Facts

HQ Location

Salt Lake City, United States

Founded

1992

Employees

1K-5K

Status

Private

Website

https://myriad.com